跳至主要内容
临床试验/NCT03193450
NCT03193450已完成不适用

Telephone-Based Re-Education of Drug Administration for Helicobacter Pylori Eradication: a Multi-Center Randomized, Controlled Study

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2017年10月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
162
试验地点
1
主要终点
Hp eradication rate

研究概览

简要总结

It was suggested that the patient compliance plans an important role in the Hp eradication. However, data on whether re-education could improve the eradication rate are lacking. We consider that re-education on patients by telephone during the process of drug administration could increase the eradication rate in Hp infected patients.

We hypothesized that telephone re-education during the whole process of drug administration would improve the compliance of patients and ultimately increase the Hp eradication rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Prior informed consent
  • •18-70 years of age
  • •Hp infected patients diagnosed by 13C urea breath test, including digestive ulcer, gastritis with dyspepsia symptoms, family history of gastric cancer, planning to use long-term non-steroidal anti-inflammatory drugs (NSAIDs), or personal request
  • •Ability to swallow oral medications
  • •No contraindication for the drugs used for Hp eradication
  • •Both men and women enrolled in this trial must use adequate barrier birth control during the course of the trial and 4 weeks after the completion of trial

排除标准

  • •Pregnant or breast-feeding subjects
  • •Previous failed treatment of Hp eradication
  • •Previous treatment with bismuth salts or antibiotics within 1 month before study enrollment, and treatment with proton pump inhibitor or H2 receptor antagonist within 2 weeks before study enrollment
  • •Any disease that could jeopardize the safety of subject and their compliance in the study (e.g. serious liver disease, heart disease, kidney disease, malignant tumor or alcoholism, etc.)
  • •Previous upper gastrointestinal surgery
  • •Inability to express complaint (e.g. mental disorder, psychoneurosis, unable to cooperation, etc.)
  • •Active clinically serious infections, except for Hepatitis B virus and hepatitis C virus infection
  • •Clinically significant gastrointestinal bleeding within 4 weeks prior to start of study drug

研究组 & 干预措施

Re-education group

Experimental

Patients in this arm will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.

干预措施: First education at the clinic (Behavioral)

Re-education group

Experimental

Patients in this arm will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.

干预措施: telephone-based re-education (Behavioral)

Non re-education group

Active Comparator

Patients in this arm only received an instruction card about the drug administration at the clinic by doctors but no re-education by telephone during treatment

干预措施: First education at the clinic (Behavioral)

结局指标

主要结局

Hp eradication rate

时间窗: 4-6 weeks after the end of drug administration

Eradication rate is the proportion of patients with eradicated-Hp. Hp infection was considered eradicated when negative results were obtained by 13carbon urea breath test at 4-6 weeks after the end of drug administration

次要结局

  • Symptoms relief rate(4-6 weeks after the end of drug administration)
  • Adverse events(4-6 weeks after the end of drug administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

He Shuixiang

Director of the Department of Gastroenterology

First Affiliated Hospital Xi'an Jiaotong University

研究点 (1)

Loading locations...

相似试验